Brain Hemorrhage clinical trials at UCLA
1 research study open to eligible people
open to eligible people ages 18-80
The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).
Los Angeles, California and other locations
Our lead scientists for Brain Hemorrhage research studies include Geoffrey Colby.